Article ID Journal Published Year Pages File Type
8234544 International Journal of Radiation Oncology*Biology*Physics 2009 10 Pages PDF
Abstract
The low-dose-rate radioimmunoconjugate 227Th-DOTA-rituximab is suitable for inactivation of single lymphoma cells and small colonies of lymphoma cells.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
In Vitro Cytotoxicity of Low-Dose-Rate Radioimmunotherapy by the Alpha-Emitting Radioimmunoconjugate Thorium-227-DOTA-Rituximab
Authors
, , , , , ,